Cargando…
Blockade of IL-36 Receptor Signaling Does Not Prevent from TNF-Induced Arthritis
INTRODUCTION: Interleukin (IL)-36α is a newly described member of the IL-1 cytokine family with a known inflammatory and pathogenic function in psoriasis. Recently, we could demonstrate that the receptor (IL-36R), its ligand IL-36α and its antagonist IL-36Ra are expressed in synovial tissue of arthr...
Autores principales: | Derer, Anja, Groetsch, Bettina, Harre, Ulrike, Böhm, Christina, Towne, Jennifer, Schett, Georg, Frey, Silke, Hueber, Axel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128584/ https://www.ncbi.nlm.nih.gov/pubmed/25111378 http://dx.doi.org/10.1371/journal.pone.0101954 |
Ejemplares similares
-
T cells as key players for bone destruction in gouty arthritis?
por: Harre, Ulrike, et al.
Publicado: (2011) -
Low-Dose Radiotherapy Ameliorates Advanced Arthritis in hTNF-α tg Mice by Particularly Positively Impacting on Bone Metabolism
por: Deloch, Lisa, et al.
Publicado: (2018) -
Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study
por: Kampylafka, Eleni, et al.
Publicado: (2018) -
The severity of experimental arthritis is independent of IL-36 receptor signaling
por: Lamacchia, Céline, et al.
Publicado: (2013) -
Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future
por: Schett, Georg, et al.
Publicado: (2011)